Pharmacological analysis of the interaction of antimuscarinic drugs at M2 and M3 muscarinic receptors in vivo using the pithed rat assay

2007 ◽  
Vol 376 (5) ◽  
pp. 341-349 ◽  
Author(s):  
Scott R. Armstrong ◽  
Sergio Briones ◽  
Brian Horger ◽  
Carrie L. Richardson ◽  
Sarah Jaw-Tsai ◽  
...  
2007 ◽  
Vol 21 (6) ◽  
Author(s):  
Scott Armstrong ◽  
Sergio Briones ◽  
Carrie Richardson ◽  
Brian Horger ◽  
Sharath Hegde

Toxicology ◽  
1994 ◽  
Vol 93 (2-3) ◽  
pp. 99-112 ◽  
Author(s):  
S. Schulte ◽  
W.E. Müller ◽  
K.D. Friedberg

1979 ◽  
Vol 168 (1) ◽  
pp. 216-218 ◽  
Author(s):  
Britta Hedlund ◽  
Marilena Gamarra ◽  
Tamas Bartfai
Keyword(s):  

1992 ◽  
Vol 12 (4) ◽  
pp. 562-570 ◽  
Author(s):  
Hans W. Müller-Gärtner ◽  
Alan A. Wilson ◽  
Robert F. Dannals ◽  
Henry N. Wagner ◽  
J. James Frost

A method to image muscarinic acetylcholine receptors (muscarinic receptors) noninvasively in human brain in vivo was developed using [123I]4-iododexetimide ([123I]IDex), [123I]4-iodolevetimide ([123I]ILev), and single photon emission computed tomography (SPECT). [123I]IDex is a high-affinity muscarinic receptor antagonist. [123I]ILev is its pharmacologically inactive enantiomer and measures nonspecific binding of [123I]IDex in vitro. Regional brain activity after tracer injection was measured in four young normal volunteers for 24 h. Regional [123I]IDex and [123I]ILev activities were correlated early after injection, but not after 1.5 h. [123I]IDex activity increased over 7–12 h in neocortex, neostriatum, and thalamus, but decreased immediately after the injection peak in cerebellum. [123I]IDex activity was highest in neostriatum, followed in rank order by neocortex, thalamus, and cerebellum. [123I]IDex activity correlated with muscarinic receptor concentrations in matching brain regions. In contrast, [123I]ILev activity decreased immediately after the injection peak in all brain regions and did not correspond to muscarinic receptor concentrations. [123I]IDex activity in neocortex and neostriatum during equilibrium was six to seven times higher than [123I]ILev activity. The data demonstrate that [123I]IDex binds specifically to muscarinic receptors in vivo, whereas [123I]ILev represents the nonspecific part of [123I]IDex binding. Subtraction of [123I]ILev from [123I]IDex images on a pixel-by-pixel basis therefore reflects specific [123I]IDex binding to muscarinic receptors. Owing to its high specific binding, [123I]IDex has the potential to measure small changes in muscarinic receptor characteristics in vivo with SPECT. The use of stereoisomerism directly to measure nonspecific binding of [123I]IDex in vivo may reduce complexity in modeling approaches to muscarinic acetylcholine receptors in human brain.


1994 ◽  
pp. 120-124 ◽  
Author(s):  
Mark R. Emmerling ◽  
Vlad E. Gregor ◽  
Roy D. Schwarz ◽  
Jeff D. Scholten ◽  
Michael J. Callahan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document